ReviewCNS drugs2021

Controversies Surrounding the Use of Long-Acting Injectable Antipsychotic Medications for the Treatment of Patients with Schizophrenia.

John M Kane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.